New studies indicate that relatively few infected cells can sustain an HIV infection. Combining this knowledge with powerful multi-drug therapy, it may now be possible to eradicate HIV in a patient within two to three years. Time will tell.
This is a preview of subscription content, log in via an institution to check access.
References
1. Chun, T.-W. etal. Nature 387, 183-188 (1997). 2. Perelson, A. S. etal. Nature387, 188-191 (1997). 3. Ho, D. D. etal. Nature373, 123-126 (1995). 4. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. Science 271, 1582-1586 (1996). 5. Wei,X. etal. Nature373, 117-122 (1995). 6. Dimitrov, D. S. etal. J. Virol. 67, 2182-2190 (1993). 7. Freitas, A. A. & Rocha, B. B. Immunol Today 14, 25-29 (1993). 8. McLean, A. R. & Michie, C. A. Proc. NatlAcad. Set. USA 92,3707-3711 (1995). 9. Wain-Hobson, S. Nature 366, 22 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wain-Hobson, S. Down or out in blood and lymph?. Nature 387, 123–124 (1997). https://doi.org/10.1038/387123a0
Issue Date:
DOI: https://doi.org/10.1038/387123a0
- Springer Nature Limited
This article is cited by
-
A method to estimate the efficiency of gene expression from an integrated retroviral vector
Retrovirology (2006)
-
The population genetics and evolutionary epidemiology of RNA viruses
Nature Reviews Microbiology (2004)
-
The causes and consequences of HIV evolution
Nature Reviews Genetics (2004)
-
Purification of RBF-2, a transcription factor with specificity for the most conservedcis-element of naturally occurring HIV-1 LTRs
Journal of Biomedical Science (1999)